Where Does Wall Street Think Reata Pharmaceuticals Inc (RETA) Stock Will Go?

Thursday, September 21, 2023 12:07 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does Wall Street Think Reata Pharmaceuticals Inc (RETA) Stock Will Go?

Analysts who follow Reata Pharmaceuticals Inc (RETA) on average expect it to decline -5.58% over the next twelve months. Those same analysts give the stock an average rating of Buy. That average rating earns RETA an Analyst Ranking of 15, which means it ranks higher than 15 of stocks, based on data compiled by InvestorsObserver.

Wall Street analysts are rating RETA a Buy today. Find out what this means to you and get the rest of the rankings on RETA!

See Full RETA Report

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With Reata Pharmaceuticals Inc Stock Today?

Reata Pharmaceuticals Inc (RETA) stock has risen 0.06% while the S&P 500 is down -1.11% as of 12:05 PM on Thursday, Sep 21. RETA has risen $0.10 from the previous closing price of $172.21 on volume of 578,058 shares. Over the past year the S&P 500 is higher by 14.86% while RETA has risen 597.05%. RETA lost -$2.99 per share the over the last 12 months. Click Here to get the full Stock Report for Reata Pharmaceuticals Inc stock.